Scott T. Rottinghaus Enanta Pharmaceuticals Inc (ENTA) insider trading activity

Scott T. Rottinghaus is Chief Medical Officer of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 22,590 shares of ENTA, which is worth approximately $154,967. The most recent transaction as insider was on Aug 08, 2025, when has been sold 2,217 shares (Common Stock) at a price of $6.99 per share, resulting in proceeds of $15,496. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.6K

8.94% 3M change

20.26% 12M change

Total Value Held $154,967

Scott T. Rottinghaus Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 08 2025	SELL Payment of exercise price or tax liability	$15,496 $6.99 p/Share	2,217 Reduced 8.94%	22,590 Common Stock
Feb 12 2025	SELL Payment of exercise price or tax liability	$15,992 $5.59 p/Share	2,861 Reduced 10.34%	24,807 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	9,750 Added 26.06%	27,668 Common Stock
Dec 06 2024	SELL Open market or private sale	$6,979 $8.06 p/Share	866 Reduced 4.61%	17,918 Common Stock
Aug 08 2024	SELL Payment of exercise price or tax liability	$18,662 $12.73 p/Share	1,466 Reduced 7.24%	18,784 Common Stock
Jul 15 2024	SELL Open market or private sale	$91,804 $17.08 p/Share	5,375 Reduced 19.84%	21,717 Common Stock
Jul 15 2024	BUY Exercise of conversion of derivative security	$48,321 $8.99 p/Share	5,375 Added 16.56%	27,092 Common Stock
Jul 12 2024	SELL Open market or private sale	$34,155 $15.04 p/Share	2,271 Reduced 9.47%	21,717 Common Stock
Jul 11 2024	SELL Open market or private sale	$64,785 $15.07 p/Share	4,299 Reduced 15.2%	23,988 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$9,369 $12.41 p/Share	755 Reduced 2.6%	28,287 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	2,576 Added 8.15%	29,042 Common Stock
Dec 05 2023	SELL Open market or private sale	$5,142 $9.63 p/Share	534 Reduced 1.98%	26,466 Common Stock
Aug 08 2023	SELL Payment of exercise price or tax liability	$25,276 $17.23 p/Share	1,467 Reduced 5.43%	25,533 Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	7,000 Added 20.59%	27,000 Common Stock
Aug 08 2022	BUY Grant, award, or other acquisition	-	20,000 Added 50.0%	20,000 Common Stock

STR

Scott T. Rottinghaus

Chief Medical Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTA shares.

Notify only if

Value

Insider Trading

Get notified when an Enanta Pharmaceuticals Inc insider buys or sells ENTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to ENANTA PHARMACEUTICALS INC

Track Activities on ENTA

Account